The liver constitutes a key organ in systemic metabolism, contributing substantially to the
development of insulin resistance and type 2 diabetes mellitus (T2DM). The mechanisms …

Non-alcoholic fatty liver disease (NAFLD) is to date the most common chronic liver disease
in clinical practice and, consequently, a major health problem worldwide. It affects …

Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …

Nonalcoholic fatty liver disease (NAFLD) is a leading etiology for chronic liver disease with
an immense public health impact and affects> 25% of the US and global population. Up to 1 …

Background & Aims We explored whether sarcopenia is associated with the histological
severity of non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis …

OBJECTIVE While vitamin E has shown to improve nonalcoholic steatohepatitis (NASH) in
patients without diabetes, information on patients with type 2 diabetes mellitus (T2DM) is …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

New evidence suggests that non-alcoholic fatty liver disease (NAFLD) has a strong
multifaceted relationship with diabetes and metabolic syndrome, and is associated with …

This review summarizes our current understanding of nonalcoholic fatty liver disease
(NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a …